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Abstract 
Herbimycin A, an inhibitor of protein tyrosine kinases, dose-dependently reduced PDGF-induced inositol phosphates (IP t) accumula- 
tion without effect on phosphatidylethanol (PEt) formation i  PLC-T 1-overexpressing NIH 3T3 (NIH 3T3~/1) cells. The compound also 
reduced tyrosine phosphorylations of some proteins including PLC-3,1 in response to PDGF. On the other hand, phorbol 12-myristate 
13-acetate (PMA)-induced phospholipase D (PLD) activation was reduced by herbimycin A in the cells, indicating that he pathways for 
PLD activation by PDGF anti PMA are different from each other. Also, these results uggest that PLC-~/1 activation is not always an 
upstream event for PLD activation and that tyrosine phosphorylation f one or more proteins not affected by herbimycin A should be 
indispensable for PLD activation i  PDGF-stimulated NIH 3T33/1 cells. 
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1. Introduction 
Activated growth factor eceptors recruit some SH2 (src 
homology 2)-containing proteins including phospholipase 
C3/1 (PLC-~/1), which stimulates hydrolysis of phospha- 
tidylinositol 4,5-bisphosphate (PIP 2) to IP 3 and DAG, lead- 
ing to protein kinase C (PKC) activation. This subse- 
quently causes activation of phospholipase D (PLD) [1]. 
PLD can also be activated through protein tyrosine kinases 
(PTKs) [2], PKC [3], Ca 2+ [4] and GTP-binding protein 
[5,6]. However, the role of a specific regulatory molecule 
for PLD activation has not yet been understood. 
Recently, it was reported that the plate-derived growth 
factor (PDGF)-induced PLD activation is a downstream 
event from PLC-'y 1 stimulation i  PLC-y 1 overexpressing 
NIH 3T3 (NIH 3T371) cells. Also, there were more 
pronounced activities of PDGF-induced PLC-~/1 and PLD 
in NIH 3T3y1 cells tharl in normal NIH 3T3 cells [7]. 
Thus, NIH 3T3~/1 cells facilitate the investigation of regu- 
lation of the enzymes concerned in signal transduction. 
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Herbimycin A, a p60 v-src tyrosine kinase inhibitor [8], 
reduced UV-induced- and Fc ER-mediated protein tyrosine 
phosphorylations i  lymphocytes [9] and in RBL-2H3 cells 
[10], respectively. Herbimycin A also inhibited Ca 2÷ mo- 
bilization induced by UV radiation [9], FceR [10], and 
PDGF in human neuroblastoma cells [11]. Tyrosine phos- 
phorylations of PLC-3tl and PLC-~/2 were prevented by 
herbimycin A in NK cells [12]. Inhibition of PLD activity 
by herbimycin A was also reported. Herbimycin A pre- 
vented phenylarsine oxide-induced PLD activation without 
effect on protein tyrosine phosphorylations in RBL-2H3 
cells [13]. However, there has been no report on the 
regulation and interrelation between PLC-~/1 and PLD in 
PDGF-induced signaling using herbimycin A. 
In this study, PLC- and PLD-activities were examined 
by measuring the levels of IP t and PEt in response to 
PDGF in NIH 3T3~/1 cells. PDGF-induced tyrosine phos- 
phorylations of intracellular proteins were consequently 
compared with the enzymatic activities of both PLC-'yl 
and PLD. It is revealed that the inhibition of tyrosine 
phosphorylations of some proteins including PLC-~/1 by 
herbimycin A does not influence PLD activation. 
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2. Mater ia l s  and  methods  
Materials. Myo-[2-3H]inositol and [3H]myristic acid 
were purchased from Amersham, Biorad AG l-X8 anion 
exchange resin was obtained from Biorad, silica F254 TLC 
plate was from Merck, phorbol 12-myristate 13-acetate 
(PMA), herbimycin A were from Sigma, monoclonal anti- 
phosphotyrosine antibody (4G10) was purchased from Up- 
state Biotech. Inc. (U.B.I.), and recombinant human 
PDGF-BB was obtained from Genzyme. 
Cell culture. NIH 3T3y 1 cells were obtained from Dr. 
P.G. Sub of Pohang University [7]. The cells were main- 
tained in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% of fetal bovine serum. 
Measurement of intraceUular inositol phosphates (lit). 
After growth to confluence, NIH 3T3y 1 cells were fasted 
in inositol-free DMEM containing 1 /xCi/ml of myo-[2- 
3H]inositol for 24 h, and berbimycin A was treated for the 
last 18 h of the labeling. The medium was exchanged with 
a new inositol-free DMEM containing 20 mM of lithium 
chloride for 15 min. Cells were stimulated with 50 ng/ml  
of PDGF at 37°C for appropriate times in the presence of 
herbimycin A, and treated with 5% of perchloric acid on 
ice for the extraction of inositol phosphates (IPt). All the 
subsequent procedures for the determination of IP t were 
performed according to a slight modification of the method 
by Fleischman et al. [14] using Biorad AG l-X8 anion-ex- 
change column. 
Measurement ofphosphatidylethnol (PEt). NIH 3T3y 1 
cells were fasted in DMEM for 24 h followed by labeling 
with 5 /~Ci/ml of [3H]myristic acid for 2 h in 60 mm 
dish. After washing with phosphate-buffered saline (PBS), 
cells were treated with 50 ng/ml  of PDGF for appropriate 
times followed by PEt analysis as described by Lee et al. 
[7]. Herbimycin A was present during all the periods from 
cell-starvation to PDGF-stimulation. 
Western blotting for phosphotyrosine proteins. NIH 
3T3yl cells in a 100-mm dish were treated with her- 
bimycin A in serum-free DMEM for 18 h. Cells were 
scraped into a tube containing 100 /zM of Na3VO 4 and 
treated with PDGF for 5 min in the presence of herbimycin 
A. Cells were then solubilized with lysis buffer containing 
20 mM HEPES, pH 7.2, 1% Triton X-100, 10% glycerol, 
50 mM NaF, 1 mM Na3VO4, 10 /xg/ml leupeptin and 1 
mM PMSF. Proteins were boiled for 5 min in loading 
buffer (50 mM Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 
0.1% bromophenol blue and 10% glycerol), elec- 
trophoresed on 8% SDS-PAGE, transferred to a nitrocellu- 
lose membrane, and the membrane blotted with anti-phos- 
photyrosine antibody (4G10). Afterlwashing with Tris- 
buffered saline (10 mM Tris-HC1, pH 8.0, 150 mM NaCI, 
and 0.05% Tween 20), the membrane was incubated with 
peroxidase-conjugated anti-mouse IgG (1/1000 dilution). 
Immunoreactive bands were visualized by the ECL West- 
ern blotting detection system. 
lmmunoprecipitation of phospholipase Cy l. Cell lysates 
were immunoprecipitated with monoclonal antibody against 
PLC-T1 preadsorbed to protein A-sepharose beads. After 
washing 5 times with RIPA buffer (50 mM Tris-HC1, pH 
8.5, 1% Triton X-100, 1% Deoxycholate, 0.1% SDS, 150 
mM NaC1, 0.05% NAN3), the beads were boiled at 95°C 
for 5 min and mixed with loading buffer. The supernatants 
were electrophoresed on 8% SDS-PAGE. The tyrosine 
phosphorylated proteins were detected by ECL as above. 
3. Resu l t s  and  d i scuss ion  
In NIH 3T3y1 cells, PEt formation reached almost 
maximum by 10 min after PDGF-stimulation while intra- 
cellular inositol phosphates OPt) increased continuously for 
30 min (Fig. 1). We analysed the effect of herbimycin A
on IP t and PEt accumulation in PDGF-stimulated NIH 
3T3y 1 cells for the measurement of PLC and PLD activi- 
ties, respectively (Fig. 2). When the cells were pretreated 
with herbimycin A for 18 h, PDGF-induced IP t accumula- 
tion was dose-dependently inhibited. However, there was 
no effect on PEt formation even at 1 /zg/ml of herbimycin 
A. In vitro, herbimycin A, even at 10 /zg/ml, did not 
reduce the activities of PLC-T1 and PLD purified from 
bovine cerebellum and porcine lung, respectively (data not 
shown). From this result, it could be expected that her- 
bimycin A inhibited tyrosine phosphorylation of PLC-T1 
since activated PDGF receptor binds SH2-containing PLC- 
y l and subsequently t rosine phosphorylates PLC-yl  for 
PIP 2 hydrolysis. Thus, the pattern of tyrosine phosphoryla- 
tions of proteins in response to PDGF was examined in 
NIH 3T3y1 cells (Fig. 3). Herbimycin A diminished 
PDGF-induced tyrosine phosphorylation f some proteins, 
notably of higher molecular weight proteins, including the 
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Fig. 1. Time course of IP t- and PEt-formations i  PDGF-stimulated NIH 
3T3y1 cells. For [3H]IPt measurement, NIH 3T3yl cells were labeled 
with 1 /zCi/ml of myo-[2-3H]inositol for 24 h. After washing, the cells 
were challenged with 50 ng/ml of PDGF, and IP t was measured at
various time intervals. As for [3H]PEt formation, fasted NIH 3T3yl cells 
were prelabeled with 5 /zCi/ml of [3H]myristic acid for 2 h before 
stimulation with 50 ng/ml of PDGF for various times. The details for the 
extraction and separation f [3H]IPt and [3H]PEt were described in
Section 2. The amount of [3H]IPt produced by 30 min after PDGF-stimu- 
lation was 146200+9300 dpm and taken as 100% value. All the points 
were represented as mean + S.D. of triplicate xperiments. 
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Fig. 2. Differential effects of herbimycin A (Her-A) on IP t (O) and PEt 
(O) formation in PDGF-stimulated NIH 3T371 cells. For [3H]IPt mea- 
surement, NIH 3T3T1 cells were labeled with 1 /xCi/ml of myo-[2- 
3H]inositol for 24 h. After washing, [3H]IPt was measured at 30 min after 
PDGF-stimulation (50 ng/ml). As for [3H]PEt formation, fastinated NIH 
3T3T1 cells were prelabeled with 5 /zCi/ml of [3H]myristic acid for 2 h 
before stimulation with 50 ng/ml of PDGF for 10 min. Herbimycin A 
was present all the times from fastination to PDGF-stimulation. The 
details for the extraction and separation of [3H]IPt and [3HI PEt were 
described in Section 2. Points were shown as means + S.D. of triplicate 
experiments. 
PDGF receptor. Immunoprecipitation with anti-PLC-71 
antibody revealed that the tyrosine phosphorylation of
PLC-T1 was also significantly reduced at 0.5 txg/ml of 
herbimycin A (Fig. 4). These results are of interests in that 
although activation of PLD has been reported to be down- 
stream of PLC-71 [7,15], reduction in tyrosine phospho- 
rylation of PLC-T1 did not affect PLD activity in this 
study. Thus, it is probable that the proteins tyrosine phos- 
phorylations which were influenced by herbimycin A may 
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Fig. 3. Inhibition of PDGF-indttced protein tyrosine phosphorylations by 
herbimycin A in NIH 3T3T1 cells. After pretreatment of herbimycin A
(her-A) for 18 h in serum-free DMEM, cells were stimulated with 50 
ng/ml of PDGF for 3 min and solubilized in lysis buffer. Thirty/xg/ml 
of the total cell proteins were electrophoresed on 8% SDS-PAGE, 
transferred to a nitrocellulose naembrane and probed with anti-phospho- 
tyrosine antibody (4G10). After reblotting with HRP-conjugated anti- 
mouse IgG, the reactions were visualized using the ECL detection 
system. The concentrations of herbimycin A are shown at the top of the 
figure in ng/ml. 
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Fig. 4. Inhibition of PDGF-induced PLC-'yI tyrosine phosphorylation by
herbimycin A in NIH 3T3T1 cells. Upper section: cell lysates were 
immunoprecipitated with monoclonal antibody to PLC-T1 followed by 
analysis of the extent of tyrosine phosphorylations a  in Fig. 3. Lower 
section: after detaching the membrane-bound antibodies, the membrane 
was reprobed with anti-PLC-T1 antibody. The concentrations of her- 
bimycin A are shown at the top of the figure in ng/ml. 
not be involved in PLD activation since PLD as well as 
PLC require protein tyrosine phosphorylations for their 
activation [2,16,17]. Furthermore, it can be suggested that 
PLC-71 is not always necessary for PLD activation and 
that other tyrosine-phosphorylated proteins not influenced 
by herbimycin A are necessary for maximal PLD activa- 
tion by PDGF-stimulation. 
Herbimycin A could inhibit either PTK- or PMA-medi- 
ated activation of PLD in cell-specific modes [13,18,19]. In 
NIH 3T3T1 cells, PMA-induced PEt formation gradually 
increased over 60 min while the PEt formation reached 
almost maximum by 10 min after PDGF-stimulation i the 
absence of herbimycin A (data not shown). However, there 
was a significant reduction in PMA-induced PEt formation 
by the pretreatment of herbimycin A for 18 h (Table 1). 
This, considering the earlier reports that PDGF could 
induce PLD activation through both PKC-dependent and 
-independent pathways [ 1,20,21 ], suggests that the pathway 
for PLD activation in response to PDGF-stimulation is
different from that stimulated by PMA in NIH 3T371 
cells. However, it cannot be concluded that herbimycin A
reduces the PMA-induced PLD activation through inhibi- 
tion of PKC-dependent process ince it has been reported 
that the effects of phorbol esters on phosphoinositide and 
Table 1 
Effect of herbimycin A on PEt formation in response to PDGF and PMA 
in NIH 3T371 cells 
Additions (%) PEt/total ipids 
None 0.32 -1- 0.05 
PDGF 1.45 + 0.12 
Hera + PDGF 1.30 -t- 0.19 
PMA 3.30-t- 0.25 
HerA + PMA 1.51 5:0.18 
After herbimycin A (HerA) pretreatment (250 ng/ml) in serum-free 
DMEM for 18 h, cells were labeled with 5 /xCi/ml of [3H]myristic acid 
for 2 h and stimulated with 50 ng/ml of PDGF (10 min) or PMA (30 
rain) in the presence of herbimycin A. All the values are expressed as 
means + S.D. of three independent experiments. 
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phosphatidylcholine hydrolysis are not mediated by PKC 
[22,23]. Hence, any inhibitory effect of herbimycin A on 
PKC-mediated intracellular processes remains to be inves- 
tigated. 
In conclusion, inhibition of the tyrosine phosphorylation 
of PLC-yl which leads to the reduction in its enzymatic 
activity does not affect PLD activation. 
Further understanding of the tyrosine-phosphorylated 
proteins responsible for PLD activation will be beneficial 
for the elucidation of the regulatory mechanisms in 
PDGF-induced signaling. 
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